Azide-Masked Fluorescence Turn-On Probe for Imaging Mycobacteria
- PMID: 37124305
- PMCID: PMC10131213
- DOI: 10.1021/jacsau.2c00449
Azide-Masked Fluorescence Turn-On Probe for Imaging Mycobacteria
Abstract
A fluorescence turn-on probe, an azide-masked and trehalose-derivatized carbazole (Tre-Cz), was developed to image mycobacteria. The fluorescence turn-on is achieved by photoactivation of the azide, which generates a fluorescent product through an efficient intramolecular C-H insertion reaction. The probe is highly specific for mycobacteria and could image mycobacteria in the presence of other Gram-positive and Gram-negative bacteria. Both the photoactivation and detection can be accomplished using a handheld UV lamp, giving a limit of detection of 103 CFU/mL, which can be visualized by the naked eye. The probe was also able to image mycobacteria spiked in sputum samples, although the detection sensitivity was lower. Studies using heat-killed, stationary-phase, and isoniazid-treated mycobacteria showed that metabolically active bacteria are required for the uptake of Tre-Cz. The uptake decreased in the presence of trehalose in a concentration-dependent manner, indicating that Tre-Cz hijacked the trehalose uptake pathway. Mechanistic studies demonstrated that the trehalose transporter LpqY-SugABC was the primary pathway for the uptake of Tre-Cz. The uptake decreased in the LpqY-SugABC deletion mutants ΔlpqY, ΔsugA, ΔsugB, and ΔsugC and fully recovered in the complemented strain of ΔsugC. For the mycolyl transferase antigen 85 complex (Ag85), however, only a slight reduction of uptake was observed in the Ag85 deletion mutant ΔAg85C, and no incorporation of Tre-Cz into the outer membrane was observed. The unique intracellular incorporation mechanism of Tre-Cz through the LpqY-SugABC transporter, which differs from other trehalose-based fluorescence probes, unlocks potential opportunities to bring molecular cargoes to mycobacteria for both fundamental studies and theranostic applications.
© 2023 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
-
- Global Tuberculosis Report; Publications of the World Health Organization, 2022.
-
- Weyer K.; Mirzayev F.; Migliori G. B.; Van Gemert W.; D’Ambrosio L.; Zignol M.; Floyd K.; Centis R.; Cirillo D. M.; Tortoli E.; Gilpin C.; de Dieu Iragena J.; Falzon D.; Raviglione M. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur. Respir. J. 2013, 42, 252–271. 10.1183/09031936.00157212. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases